Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_6042_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
14 Мб
Скачать
☆
230

70.7 Management

Methods adopted are:
• Plasmapheresis is helpful
• IV human immunoglobulin therapy as an alternative
• Steroid therapy is not so helpful
• Prevention of all kinds of infection in patients with BMT
• In severe GVHD immunosuppression may be considered

References

Finkelstein JS, Melek BH. Guillain-Barré syndrome as a cause of reversible cardiomyopathy. Tex
Heart Inst J. 2006;33(1):57–9. Hadden RD, Karch H, Hartung HP, et al. Preceding infections, immune factors, and outcome in
Guillain-Barré syndrome. Neurology. 2001;56(6):758–65. Hagensee ME, Benyunes M, Miller JA, Spach DH. Campylobacter jejuni bacteremia and Guillain-
Barré syndrome in a patient with GVHD after allogeneic BMT. Bone Marrow Transplant.
1994;13(3):349–51. Jacobs BC, Van doorn PA, Schmitz PI, et al. Campylobacter jejuni infections and anti-GM1 anti-
bodies in Guillain-Barré syndrome. Ann Neurol. 1996;40(2):181–7. Marosi C, Budka H, Grimm G, et al. Fatal encephalitis in a patient with chronic graft-versus-host
disease. Bone Marrow Transplant. 1990;6(1):53–7. Mohrmann RL, Mah V, Vinters HV. Neuropathologic fi ndings after bone marrow transplantation:
an autopsy study. Hum Pathol. 1990;21(6):630–9. Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-
Barré syndrome. N Engl J Med. 1995;333(21):1374–9. Rowland LP, Pedley TA. Merritt’s Neurology. Philadelphia, PA: Lippincott Williams & Wilkins;
2010.
Speed BR, Kaldor J. Guillain-Barré syndrome associated with Campylobacter infection. Aust N Z
J Med. 1985;15(2):269. Tam CC, Rodrigues LC, O’brien SJ. Guillain-Barré syndrome associated with Campylobacter
jejuni infection in England, 2000-2001. Clin Infect Dis. 2003;37(2):307–10. Wen PY, Alyea EP, Simon D, Herbst RS, Soiffer RJ, Antin JH. Guillain-Barré syndrome following
allogeneic bone marrow transplantation. Neurology. 1997;49(6):1711–4.
70 Guillain-Barré Syndrome Following Allogeneic Bone Marrow Transplantation
231
© Springer International Publishing Switzerland 2016 I.M. Eltorai, Rare Diseases and Syndromes of the Spinal Cord, DOI 10.1007/978-3-319-45147-3_71
7 1

Myelopathy due to Cladosporium trichoides or Cladophialophora bantiana

71.1 Definition

Cladosporium trichoides is also known as Cladophialophora bantiana. C. bantiana is a rare dematiaceous fungus, which is distributed worldwide (see McGinnis et al. 1986 , for further details about the fungus).

71.2 Incidence and Etiology

Only one case, reported by Lopes et al., is summarized here. In the brain this infec­tion is more common. This usually results in fungal brain abscess (see Raut et al., 2003 and Levin et al. 2004 ). Intracranial fungal infections occur in patients on long antibiotic and steroid therapies, low immunity, and debility are predisposing factors. The fungus is present in decaying vegetation, soil, and wood. Occupational expo­sure by inhalation of soil is important. Trauma may precede the infection (Dixon et al.
1989 ).

71.3 Pathology

This fungus route of entry is unknown. The most accepted theory is that the route of entry is through inhalation of spores. The fungus is abundantly found in skin, lungs, gastrointestinal tract, infection of the paranasal sinuses, and the ears has been reported. Hematogenous spread to the route of the central nervous system (CNS) infection. This may be parenchymal or meningeal.
In the case report the pathological report was as follows:
Abstracted from Lopes et al. ( 1989 )
232
Morphology: an intradural granulomatous mass extramedullary fi brous tissue with
necrotic foci, adherent to the distal medulla and to the upper cervical cord. Microscopically: chronic infl ammation with giant cells containing fungal frag-
ments. Hyphae and spherical bodies are seen. The hyphae are segmented and
stain golden yellow.
The fungus had a positive picture by using Grocott-Fontana-Masson technique. Its morphological and histochemical characteristics suggest the diagnosis of c. ban- tiana. Gomori-methenamine silver stain confi rms the presence of fungal hyphae; cultures show c. bantiana.

71.4 Clinical Picture

The authors discuss the epidemiology and reviewed the cerebral infection cases. Their 25-year-old patient presented with progressive weakness and paralysis of all his extremities with sphincteric disturbances. Clinically he was tetraplegic without sensory loss and his refl exes were exaggerated.

71.5 Diagnosis

Diagnosis is based on the following criteria:
1. Clinical exam: A 25-year-old male, tetraplegic, with marked loss of weight and
atrophy of the extremities.
2. Myelogram showed complete occipito-cervical block.
3. MRI was not included
4. Hydrocephalus was detected and shunted.
5. Lumbar and suboccipital puncture showed signs of infi ltration i.e. increased
lymphocytes, granulocytes, monocytes, plasma cells, and high proteins.

71.6 Management

1. Hydrocephalus: ventriculo-peritoneal shunt
2. High cervical compression: suboccipital decompression and laminectomy
C1-C2
In general CNS fungal infections are serious and morbidity is high. The patient reported expired a few days post-op. Anti-fungal chemotherapy is still ineffective. Amphotericin B IV: intrathecally have been used as well as Fluorocytosine in brain abscess.
71 Myelopathy due to Cladosporium trichoides or Cladophialophora bantiana
233
71.6.1 Another Picture of Spinal Cord
Shields and Castillo ( 2002 ) report a case of spinal involvement by C. bantiana caus- ing transverse myelitis. A 53-year-old woman who is on steroids for sarcoidosis developed paraparesis with sensory level about T12. The case was diagnosed by cord biopsy, which showed C. bantiana . The lesion being localized (not diffused), excision biopsy and anti-fungal therapy gave a favorable result.

References

Lopes MBS, Barbosa RF, Vellasco O, Rosemberg S. Cervical cord compression due to
Cladosporium trichoides. Anatomo-clinic obersvation [in French]. Ann Pathol.
1989;9(4):275–8. Dixon DM, Walsh TJ, Merz WG, McGinnis MR. Infections due to Xylophypha bantiana
(Cladosporium trichoides) . Rev Infect Dis. 1989;2:515–23. McGinnis MR, Borelli D, Padhye AA, Ajello L. Reclassifi cation of Cladosporium bantianum in
the genus Xylohypha . J Clin Microbiol. 1986;23(6):1148–51. Raut A, Muzumdar D, Narlawar R, Nagar A, Ahmed N, Hira P. Cerebral abscess caused by
Cladosporium bantianum infection. Neurol Med Chir (Tokyo). 2003;43:413–5. Shields GS, Castillo M. Myelitis caused by Cladophialophora bantiana . AJR Am J Roentgenol.
2002;179(1):278–9. Levin TP, Baty DE, Fekete T, Truant AL, Suh B. Cladophialophora bantiana brain abscess in a
solid-organ transplant recipient: case report and review of the literature. J Clin Microbiol.
2004;42(9):4374–8.
References
235
© Springer International Publishing Switzerland 2016 I.M. Eltorai, Rare Diseases and Syndromes of the Spinal Cord, DOI 10.1007/978-3-319-45147-3_72
7 2

Coxsackie Transverse Myelitis

72.1 Definition

There are two principal groups of Coxsackie virus:
• Group A: these are divided into 24 serotypes
• Group B: these are divided into 6 serotypes
Acute transverse myelitis (ATM) is a rare clinical manifestation of Coxsackie virus infection which causes an acute and progressive debilitating illness associated with loss of spinal cord functions both motor and sensory.

72.2 Incidence

Acute transverse myelitis has been rarely associated with Coxsackie virus. There have been a few cases reported due to Coxsackie viruses. Coxsackie virus is associ­ated with other diseases of the CNS: aseptic meningitis, encephalitis, Guillian-Barré syndrome, and poliomyelitis. Coxsackie A7, A9, A23, and Coxsackie virus B strains frequently cause encephalomyelitis often associated with transient or permanent paralysis (Gear 1984 ; Lemer and Finland 1961 ). One case of transverse myelitis was reported by Dery et al., in 1974, caused by Coxsackie virus type B4; B3 strain by Mathews and Bailey, in 1977. Other cases of coxsackie’s ATM include the A9 strain by Graber et al. in 1994; the B4 strain by Ku and Lee in 1998; and the case by Minami et al., 2004, with the B5 strain. In 2005, Strarakis et al., reported a brief case of B2 Coxsackie virus causing ATM.
Abstracted from Minami et al. ( 2004 ) and Starakis et al. ( 2005 )
236

72.3 Etiology

Various infectious agents have been described as the cause of ATM, 20–40 % of these are attributed to viruses, although a specifi c virus has been rarely identifi ed (Ku and Lee 1998 ).

72.4 Pathology

Pathogenesis of ATM: according to Minami et al., there are three hypotheses for the pathogenesis of ATM:
1. cell mediated post-infectious autoimmune response
2. direct viral invasion of the spinal cord
3. acute vascular occlusion
Sometimes a raised Coxsackie virus antibody is detected in the serum. Rarely this virus is found in the CSF, but it may be detected in the stools. Sometimes it is diffi cult to distinguish between autoimmune reaction and direct viral invasion. Pathologically several spinal cord segments are usually involved. In some cases the process is mainly a demyelination in others necrosis involves all cord elements. There are perivenous lymphocytes with areas of demyelination and microglial reac­tion. Superimposed ischemia and possibly vascular spasm may play a role, but one necroscopy shows necrotizing anterior spinal elements and cystic myelomalacia (Tyler et al. 1986 ).

72.5 Clinical Picture

There may be a history of respiratory infection or diarrhea or other manifestations of Coxsackie viral disease, but not necessarily so. It might be rather acute onset of paraplegia with or without sensory loss and with sphincter dysfunction. It is mani­fested usually within hours, days, up to a week. The previous history of viral disease (fl u) suggests an immune-mediated pathogenesis. There is fl accid paralysis with loss of the refl exes including the rectal and bulbocavernous refl exes. Sensory loss may be associated with the motor loss. The picture is not specifi c for Coxsackie viruses, but occurs with other viral infections, and sometimes ATM is idiopathic. The course of the disease is variable depending on the time of the diagnosis and the effi ciency of the management. Early management may lead to complete recovery motor and sensory-wise within months, and occurs in one-third of the cases; one­third gets partial recovery and one-third become chronically disabled and some of them die. Poor prognostic signs include extensive paralysis, widespread abnormal changes in the cord in the MRI and abnormal fi ndings in somatosensory evoked potentials. Other CNS viral infections add to the risks.
72 Coxsackie Transverse Myelitis
237

72.6 Diagnosis

Diagnosis is base on:
1. Neurological exam
2. MRI of the spinal cord: (from Ku and Lee, for further details see their report)
MRI is considered the best diagnostic modality in the intramedullary space.
Common MRI fi ndings of ATM are fusiform swelling of the cord having
increased signal intensity with occasional gadolinium enhancement in T2
weighted sagittal scan and centrally located hyper-intensity of the cross-sectional
area of the cord with variable enhancement in T2-weighted axial scan. Long-
term follow-up may show atrophy with increased sagittal intensity on T2
weighted sequence consistent with myelomalacia and gliosis.
3. Serology: may show antibodies raised against Coxsackie virus and can be dem-
onstrated in serum.
4. Cerebral spinal fl uid (CSF): There is increasing of Coxsackie specifi c antibodies
in the CSF due to two possibilities, either diffusion from the serum or local pro-
duction from CNS. There is increased γ-globulin in the CSF and lymphocytes.
Diagnosis of Coxsackie virus in the CSF is possible in half of the cases. Serum
ratio of neutralizing antibody titres can be used as serological test for diagnosis
and follow up during convalescence by comparison. Ku and Lee think that eight
fold or greater neutralizing antibodies titres is diagnostic.
5. Tissue biopsy, if available, may grow the virus
6. Myelogram may be needed to rule out extramedullary lesions; however, MRI is
the gold standard
7. Electrophysiological studies are useful diagnostic measures and if the changes
persist during convalescence this indicates poor prognosis.
8. Stools for Coxsackie virus
72.7 Management
There is no consensus in the literature regarding the best treatment of ATM. Steroids in low doses or other specifi c treatment has no infl uence on the outcome of the disease (Ku and Lee et al. 1998 ). Intravenous methylpredinsolone has an anti- infl ammatory effect in vivo and in vitro. Combined with cyclophosphamide in ATM due to SLE gave better results than prednisolone alone. Methylpredinsolone seems to be safe and effective in ATM in children. As an example Minami et al., treated a child 6 years old by IV methylpredinsolone 1000 mg IV daily for three consecutive days per week for 3 weeks followed by oral prednisolone (1 mg/kg/ day) after which the patient’s neurological condition had improved. The serum titre for neutralizing Coxsackie antibody against Coxsackie virus rose from ¼ to 1/256 1 month later.

72.7 Management

238

References

Gear JH. Nonpolio causes of polio-like paralytic syndromes. Rev Infect Dis. 1984;6(2):S379–84. Ku B, Lee K. Acute transverse myelitis caused by Coxsackie virus B4 infection: a case report.
J Korean Med Sci. 1998;13(4):449–53. Lerner AM, Finland M. Coxsackie viral infections. Arch Intern Med. 1961;108:329–34. Minami K, Tsuda Y, Maeda H, Yanagawa T, Izumi G, Yoshikawa N. Acute transverse myelitis
caused by Coxsackie virus B5 infection. J Paediatr Child Health. 2004;40(1–2):66–8. Starakis I, Marangos M, Giali S, Bassaris H. Acute transverse myelitis due to Coxsackie virus.
J Clin Neurosci. 2005;12(3):296–8. Tyler KL, Gross RA, Cascino GD. Unusual viral causes of transverse myelitis: hepatitis A virus
and cytomegalovirus. Neurology. 1986;36(6):855–8.
72 Coxsackie Transverse Myelitis
239
© Springer International Publishing Switzerland 2016 I.M. Eltorai, Rare Diseases and Syndromes of the Spinal Cord, DOI 10.1007/978-3-319-45147-3_73
7 3

Cytomegalovirus Myelitis

73.1 Definition

This is a condition in which there is loss of motor and sensory functions and auto­nomic and sphincteric dysfunctions associated with cytomegaly virus (CMV) infection.

73.2 Incidence

According to Fux et al., there is an incidence of 1.3–4.6 cases per million per year. The disease viscerally develops in immunocompromised patients. Fux et al., reviewed the literature and found only eight cases in Immunocompetent patients and added one case of their own.

73.3 Etiology

Acute transverse myelitis (ATM) is caused by many viruses, including CMV. Approximately 40 % of ATM are preceded by infection herpes simplex virus (HSV), varicella-zoster virus (VZV), Epstein-Barr virus (EBV), enterovirus, hepa­titis, measles, mumps, mycoplasma pneumoniae , or CMV. The pathological changes occur due to direct viral infection and autoimmune mechanisms.

73.4 Pathology

The changes in the nerve tissue are due to:
Fux et al. ( 2003 )
240
• Direct infection by the virus
• Autoimmune reaction
• According to Kerr and Ayetey ( 2002 ): there is an element of vasculitis and gran-
ulomatous formation.
There is intraparenchymal and perivascular cellular infi ltration in the spinal cord resulting in demyelination and neuronal injury. According to Fux et al. ( 2003 ), the pathophysiologic changes include molecular mimicry and the fulminant activation of lymphocytes by microbial super-antigens. In addition high levels of circulating antibodies may cause ATM by immune complex deposition.

73.5 Clinical Picture

The disease starts with back pain followed by neurologic manifestations acutely or subacutely. The manifestations of ATM following fever and chills and fl u like cough for 1–2 weeks are:
• Paraparesis
• Ascending sensory loss
• Autonomic dysfunctions and spinal shock of variable degree
• Sphincteric dysfunction usually urinary retention and obstipation
• Occasionally cerebral manifestations

73.6 Diagnosis

1. Clinical history in an autoimmune competent patient
2. Blood picture is usually normal except in the presence of atypical lymphocytes
(7.5 %)
3. CMV antigen may be detected
4. Active CMV IgM and IgG are positive and elevated in serum
5. Infections with other viruses need to be ruled out, e.g. HIV, VZV, tick-borne
encephalitis, measles, mumps, mycoplasma pneumoniae, Toxoplasma gondii,
Borrelia, Rickettsia, Treponema pallidum were all negative.
6. CSF: pleocytosis mononuclear 98 %, proteins elevated, CMV antibodies may be
negative, CSF polymerase chain reaction (PCR) may be in 40–50 % negative for
CMV DNA, but being positive confi rms diagnosis.
7. MRI shows infl ammatory regions but it may be within normal limits in 40–50 %
of patients.

73.7 Management

• Ganciclovir (5 mg/kg BID ×14 days)
• Methylpredinsolone IV (500 mg/QD ×5 days)
73 Cytomegalovirus Myelitis